● Nā maʻi hanu
-
ʻO ka Mycoplasma Pneumoniae (MP)
Hoʻohana ʻia kēia huahana no ka ʻike qualitative in vitro o ka Mycoplasma pneumoniae (MP) nucleic acid i loko o ka sputum kanaka a me nā laʻana swab oropharyngeal.
-
ʻO ka maʻi Influenza A Universal/H1/H3
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka maʻi influenza A universal type, H1 type a me H3 type nucleic acid i nā laʻana swab nasopharyngeal kanaka.
-
ʻO Adenovirus Universal
Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o ka adenovirus nucleic acid i loko o ka nasopharyngeal swab a me ka ʻāʻī swab laʻana.
-
4 ʻAno o nā maʻi hanu
Hoʻohana ʻia kēia kime no ka ʻike ʻana i ka qualitative o2019-nCoV, ka maʻi influenza A, ka maʻi influenza B a me ka maʻi respiratory syncytial nucleic acidsi loko o ke kanakaonā hāpana swab ropharyngeal.
-
12 ʻAno o ka maʻi hanu
Hoʻohana ʻia kēia kit no ka hui ʻana o ka qualitative detection o SARS-CoV-2, influenza A virus, influenza B virus, adenovirus, mycoplasma pneumoniae, rhinovirus, respiratory syncytial virus a me parainfluenza virus (Ⅰ, II, III, IV) a me metapneumovirus kanaka i loko o nā swabs oropharyngeal..
-
ʻO ka maʻi hanu o ka Hikina Waena Coronavirus Nucleic Acid
Hoʻohana ʻia ka pahu hana no ka ʻike qualitative o ka MERS coronavirus nucleic acid i loko o nā swabs nasopharyngeal me ka Middle East Respiratory Syndrome (MERS) coronavirus.
-
19 ʻAno o ka Pathogen Hanu Nucleic Acid
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka SARS-CoV-2, ka maʻi influenza A, ka maʻi influenza B, adenovirus, mycoplasma pneumoniae, chlamydia pneumoniae, ka maʻi respiratory syncytial a me ka maʻi parainfluenza (Ⅰ, II, III, IV) i loko o nā swabs puʻu a me nā laʻana sputum, human metapneumovirus, haemophilus influenzae, streptococcus pneumoniae, klebsiella pneumoniae, staphylococcus aureus, pseudomonas aeruginosa, legionella pneumophila a me acinetobacter baumannii.
-
4 ʻAno o nā maʻi hanu Nucleic Acid
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka SARS-CoV-2, ka maʻi influenza A, ka maʻi influenza B a me nā waikawa nucleic virus syncytial respiratory i loko o nā hāpana swab oropharyngeal kanaka.
-
ʻO ka waikawa nucleic Cytomegalovirus kanaka (HCMV)
Hoʻohana ʻia kēia pahu hana no ka hoʻoholo qualitative o nā waikawa nucleic i loko o nā laʻana e like me ke serum a i ʻole ka plasma mai nā poʻe maʻi me ka maʻi HCMV i manaʻo ʻia, i mea e kōkua ai i ka ʻike ʻana i ka maʻi HCMV.
-
ʻAkika Nukleika o ka maʻi EB
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka EBV i loko o ke koko holoʻokoʻa o ke kanaka, ka plasma a me nā laʻana serum in vitro.
-
ʻEono ʻano o nā maʻi hanu
Hiki ke hoʻohana ʻia kēia pahu hana e ʻike pono i ka waikawa nucleic o SARS-CoV-2, ka maʻi influenza A, ka maʻi influenza B, adenovirus, mycoplasma pneumoniae a me ka maʻi respiratory syncytial in vitro.
-
ʻO AdV Universal a me ka ʻAno 41 Nucleic Acid
Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative in vitro o ka adenovirus nucleic acid i loko o nā swabs nasopharyngeal, nā swabs ʻāʻī a me nā laʻana ʻōpala.
